Zoetis, Inc. (ZTS)
69.69
+0.59
(+0.85%)
USD |
NYSE |
Oct 02, 16:00
69.27
-0.42
(-0.60%)
Pre-Market: 20:00
Zoetis EPS Diluted (Quarterly) : 1.654 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.654 |
| March 31, 2026 | 1.423 |
| December 31, 2025 | 1.375 |
| September 30, 2025 | 1.627 |
| June 30, 2025 | 1.630 |
| March 31, 2025 | 1.344 |
| December 31, 2024 | 1.288 |
| September 30, 2024 | 1.504 |
| June 30, 2024 | 1.368 |
| March 31, 2024 | 1.306 |
| December 31, 2023 | 1.141 |
| September 30, 2023 | 1.292 |
| June 30, 2023 | 1.450 |
| March 31, 2023 | 1.188 |
| December 31, 2022 | 0.9876 |
| September 30, 2022 | 1.128 |
| June 30, 2022 | 1.122 |
| March 31, 2022 | 1.255 |
| December 31, 2021 | 0.8705 |
| September 30, 2021 | 1.159 |
| June 30, 2021 | 1.073 |
| March 31, 2021 | 1.170 |
| December 31, 2020 | 0.75 |
| September 30, 2020 | 1.001 |
| June 30, 2020 | 0.7885 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8831 |
| December 31, 2019 | 0.7997 |
| September 30, 2019 | 0.8993 |
| June 30, 2019 | 0.7692 |
| March 31, 2019 | 0.6458 |
| December 31, 2018 | 0.7121 |
| September 30, 2018 | 0.7143 |
| June 30, 2018 | 0.79 |
| March 31, 2018 | 0.72 |
| December 31, 2017 | 0.16 |
| September 30, 2017 | 0.61 |
| June 30, 2017 | 0.50 |
| March 31, 2017 | 0.48 |
| December 31, 2016 | 0.31 |
| September 30, 2016 | 0.48 |
| June 30, 2016 | 0.45 |
| March 31, 2016 | 0.41 |
| December 31, 2015 | 0.04 |
| September 30, 2015 | 0.38 |
| June 30, 2015 | -0.07 |
| March 31, 2015 | 0.33 |
| December 31, 2014 | 0.25 |
| September 30, 2014 | 0.33 |
| June 30, 2014 | 0.27 |
| March 31, 2014 | 0.31 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.939 |
| Merck & Co., Inc. | -0.5405 |
| Elanco Animal Health, Inc. | 0.1067 |
| Pfizer Inc. | -0.0435 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 691.00M |
| Revenue (Quarterly) | 2.468B |
| Total Expenses (Quarterly) | 1.777B |
| Enterprise Value | 36.42B |
| Gross Profit Margin (Quarterly) | 71.47% |
| Profit Margin (Quarterly) | 28.00% |
| Earnings Yield | 8.72% |
| Operating Earnings Yield | 11.94% |
| Normalized Earnings Yield | 9.016 |